WEED2 - Overview: Weed Panel # 2, Serum
Establishing a diagnosis of an allergy to English plantain, lamb's quarters, mugwort, scale, and Western ragweed allergen Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic...
WEED3 - Overview: Weed Panel # 3, Serum
Establishing a diagnosis of an allergy to English plantain, lamb's quarters, red sorrel, and Russian thistle allergen Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic...
WEED1 - Overview: Weed Panel # 1, Serum
Establishing a diagnosis of an allergy to English plantain, lamb's quarters, mugwort, Russian thistle, and short ragweed allergen Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for...
WEED4 - Overview: Weed Panel # 4, Serum
Establishing a diagnosis of an allergy to giant ragweed, short ragweed, and Western ragweed Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic...
ZW1 - Overview: Miscellaneous MML Referral Test 1
Miscellaneous MML Referral Test 1
ZW143 - Overview: Miscellaneous IMMCO Diagnostics
Miscellaneous IMMCO Diagnostics
ZW298 - Overview: Miscellaneous IntrinsicDx
Miscellaneous IntrinsicDx
G6PD1 - Overview: Glucose 6-Phosphate Dehydrogenase Enzyme Activity, Blood
Evaluation of individuals with episodic or chronic Coombs-negative nonspherocytic hemolytic anemia Rapid testing to assess glucose 6-phosphate dehydrogenase (G6PD) enzyme capacity prior to rasburicase or other therapies that may cause...
H2BR - Overview: HER2 Amplification Associated with Breast Cancer, FISH, Tissue
A predictive marker for patients with both node-positive or node-negative primary and metastatic breast cancer Patients with HER2 amplification that may be candidates for therapies targeting the human epidermal growth factor receptor 2...
Evaluation of known or suspected hematologic neoplasms, specifically of myeloid origin (eg, acute myeloid leukemia, myelodysplastic syndrome, myeloproliferative neoplasm, myelodysplastic/myeloproliferative neoplasm, unexplained cytopenias)...
Mayo Now Has Two Ninjas in the House - Insights
Candace Granberg, M.D., has a lot of titles, including surgeon, wife, mom, and volunteer. Now, she can add another: ninja warrior. The pediatric urologist is the second Mayo staff member chosen to participate...
The State of COVID-19 Now: Dr. Bill Morice - Insights
M.D. This week, Dr. Morice and Dr. Pritt step back and look at where the COVID-19 pandemic stands now, and they consider the potential effects that the omicron variant, expanded testing availability, and...
rights reserved. 07/2021 Hepatitis E: Testing Algorithm for Diagnosis and Management Immunocompetent patients with abnormal liver enzyme levels and at risk for hepatitis E virus (HEV) Immun......
Infliximab Test Now Validated for Inflectra - Insights
Mayo Clinic has completed validation of its existing Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum test for the new biosimilar
New phlebotomy modules now available - Insights
Mayo Clinic Laboratories Education is pleased to announce the release of six new phlebotomy learning modules, which encompass many of the necessary skills to further your journey as a phlebotomist.